Lite Strategy, Inc.
LITS
Rank in Stocks
#24971
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm,... Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.
Share Price
$0.9495
Last synced: 2026-11-09
Market Cap
$28.87M
Change (1 day)
-6.91%
Change (1 year)
-50.03%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Lite Strategy, Inc. (LITS)
Category
Healthcare
Operating Margin for Lite Strategy, Inc. (LITS)
Operating Margin as of November 2026 TTM: 0.00%
According to Lite Strategy, Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Lite Strategy, Inc. from 2021 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | -100.00% |
| 2024 | 22.27% | -129.57% |
| 2023 | -75.31% | -59.40% |
| 2022 | -185.48% | 6.81% |
| 2021 | -173.65% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
|
| 29.35% | - |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Lite Strategy, Inc.'s operating margin
What was Lite Strategy, Inc.'s operating margin in 2025?
In 2025, Lite Strategy, Inc.'s operating margin was 0.00%, compared with 22.27% in 2024.
How has Lite Strategy, Inc.'s operating margin changed since 2021?
From 2021 to 2025, Lite Strategy, Inc.'s operating margin was highest in 2024 (22.27%) and lowest in 2022 (-185.48%).
How does Lite Strategy, Inc.'s operating margin compare with similar companies?
Lite Strategy, Inc.'s operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.